August 29, 2018

Media

Media & events

news

Lyndra Therapeutics to Develop Once-Monthly Oral Contraceptive

July 30, 2019
Lyndra Therapeutics to Develop Once-Monthly Oral Contraceptive $13 Million Bill & Melinda Gates Foundation Grant to Fund Development Program to...
Read More
1 2 3 13

publications

  • A pharmaceutical answer to non-adherence: Once weekly oral memantine for Alzheimer’s disease
    A pharmaceutical answer to non-adherence: Once weekly oral memantine for Alzheimer’s disease
1 2 3 5
200px-Elsevier.svg
200px-Elsevier.svg
A pharmaceutical answer to non-adherence: Once weekly oral memantine for Alzheimer’s disease

Rosemary Kanasty, Susan Low, Nupura Bhise, JungYanga, ErickPeeke, MarleneSchwarz, JimWright, BennettCarter, SaumyaMoorthy, TylerGrant, BenDeBenedictis, MeganBishoff, CraigSimsesAndrew M.Bellinger

URL : View Project

awardS

Amy Schulman, Lyndra Co-founder and CEO, honored on 2019 PharmaVOICE 100

“Amy’s fearless approach to create durable value and change the trajectory of compliance for some of most difficult to treat diseases —  Alzheimer’s disease, HIV, opioid use disorder, and schizophrenia — are just a couple of the reasons she has been identified as one of the 100 most inspiring people in the life-sciences industry,” says Taren Grom, editor, PharmaVOICE

#PharmaVOICE

2019 Xconomy Awards Finalist in Startup Category

We are honored to be named a finalist for the Awards in the category for our work making daily pills a thing of the past.

#XconomyAwards

events

Lyndra Presents @ BIO International

Join us on Thursday, June 5th, at 5pm when Andrew Bellinger, our CSO, presents our 2019 Company Update at BIO International, Philadelphia Convention Center, Theater 4

2019 BIO International